Codexis is a clean technology company that develops of optimized biocatalysts that make industrial processes faster, cleaner and more efficient.
As per the pact, DSP will use Codexis’ biocatalysis screening products in selected undisclosed therapeutic products in its development pipeline.
Codexis Pharmaceutical Services and Enzyme Products president Joseph Sarret said DSP has identified Codexis technology as a key component in its drive to develop green, sustainable manufacturing processes to serve their key markets, and they look forward to a productive partnership.